On the contrary, TRPM8 expression decreases pancreatic cancer cell sensitivity to the chemotherapeutic gemcitabine, which is associated with changes in the expression of proteins responsible for multidrug resistance, apoptosis, and gemcitabine metabolism (Liu J. F. et al., 2018). This evidence concerns the gene TRPM8 and familial pancreatic carcinoma.